• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病患者更喜欢溶液剂和泡沫剂剂型:剂型偏好的定量评估

Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference.

作者信息

Housman Tamara Salam, Mellen Beverly G, Rapp Stephen R, Fleischer Alan B, Feldman Steven R

机构信息

Department of Dermatology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA.

出版信息

Cutis. 2002 Dec;70(6):327-32.

PMID:12502121
Abstract

Psoriasis patients' acceptance of the vehicles used in topical therapy contributes to adherence to treatment plans and outcomes, but patient preferences for different vehicles have not been assessed. The purpose of this study was to develop a quantitative measure of patient preferences for different vehicles and to assess these preferences. Focus group sessions were conducted of patients with psoriasis to determine patient perceptions of the advantages and disadvantages of different topical psoriasis therapies. This information was used to derive a vehicle preference measure to assess different topical therapies. Twenty patients with psoriasis sampled different topical psoriasis medications, assessed the effects of the vehicles on quality of life (QOL), and completed the preference measure for each vehicle. The focus group sessions resulted in the development of a 7-item preference measure. The validity of the vehicle preference measure was demonstrated by good correlation with patient expectations of effects on QOL and by test-retest reliability. The foam and solution vehicles were preferred over the cream, gel, and ointment vehicles (P < .01). There was no significant difference between preferences for daytime and nighttime application of vehicles. Although validated measures of adherence to topical therapy are not yet available, the results of this study suggest that the characteristics of solution and foam may favor improved adherence to topical therapy.

摘要

银屑病患者对局部治疗所用载体的接受程度有助于其坚持治疗方案并取得治疗效果,但尚未对患者对不同载体的偏好进行评估。本研究的目的是开发一种定量方法来衡量患者对不同载体的偏好,并评估这些偏好。对银屑病患者进行了焦点小组讨论,以确定患者对不同局部银屑病治疗方法优缺点的看法。这些信息被用于推导一种载体偏好衡量方法,以评估不同的局部治疗方法。20名银屑病患者试用了不同的局部银屑病药物,评估了载体对生活质量(QOL)的影响,并完成了对每种载体的偏好衡量。焦点小组讨论产生了一种包含7个条目的偏好衡量方法。载体偏好衡量方法的有效性通过与患者对生活质量影响的预期的良好相关性以及重测信度得到了证明。泡沫剂和溶液剂载体比乳膏剂、凝胶剂和软膏剂载体更受青睐(P < .01)。载体在白天和夜间使用的偏好之间没有显著差异。尽管尚未有经过验证的局部治疗依从性衡量方法,但本研究结果表明,溶液剂和泡沫剂的特性可能有利于提高局部治疗的依从性。

相似文献

1
Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference.银屑病患者更喜欢溶液剂和泡沫剂剂型:剂型偏好的定量评估
Cutis. 2002 Dec;70(6):327-32.
2
Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.药物剂型影响生活质量:一项关于0.05%丙酸氯倍他索泡沫剂与0.05%丙酸氯倍他索乳膏和0.05%溶液联合方案治疗银屑病的随机单盲研究。
Cutis. 2003 Nov;72(5):407-11.
3
Patients preferences for different corticosteroid vehicles are highly variable.患者对不同皮质类固醇载体的偏好差异很大。
J Dermatolog Treat. 2020 Mar;31(2):147-151. doi: 10.1080/09546634.2018.1473837. Epub 2019 Oct 10.
4
Patients' vehicle preference for corticosteroid treatments of scalp psoriasis.头皮银屑病皮质类固醇治疗的患者用药偏好
Am J Clin Dermatol. 2003;4(4):221-4. doi: 10.2165/00128071-200304040-00001.
5
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.一日两次使用卡泊三醇软膏与一日一次短期接触地蒽酚乳膏疗法的比较:日间护理环境中银屑病监督治疗随机对照试验的生活质量结果
Br J Dermatol. 2008 Feb;158(2):375-81. doi: 10.1111/j.1365-2133.2007.08337.x. Epub 2007 Dec 7.
6
Increasing use of non-traditional vehicles for psoriasis and other inflammatory skin conditions.非传统疗法在银屑病和其他炎症性皮肤病治疗中的应用日益增加。
Dermatol Online J. 2014 Sep 16;20(9):13030/qt58v1g0kq.
7
Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis.评估用于治疗痤疮、特应性皮炎和斑块状银屑病的外用制剂的特性。
Cutis. 2014 Jul;94(1):46-53.
8
Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.一种外观可接受的煤焦油溶液治疗中度斑块状银屑病的疗效和耐受性:与卡泊三醇乳膏(卡泊三醇)的对照比较。
Am J Clin Dermatol. 2010;11(4):275-83. doi: 10.2165/11530380-000000000-00000.
9
Are ointments better than other vehicles for corticosteroid treatment of psoriasis?在银屑病的皮质类固醇治疗中,软膏剂比其他剂型更好吗?
J Drugs Dermatol. 2009 Jun;8(6):570-2.
10
Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles.泡沫剂型的局部用皮质类固醇与传统剂型相比,覆盖范围相当。
J Am Acad Dermatol. 2000 Jun;42(6):1017-20.

引用本文的文献

1
Noncorticosteroid Topical Therapies for the Treatment of Plaque Psoriasis: A Narrative Review.用于治疗斑块状银屑病的非皮质类固醇外用疗法:一项叙述性综述
J Pharm Technol. 2023 Oct;39(5):247-255. doi: 10.1177/87551225231193057. Epub 2023 Aug 19.
2
Patient-Centric Design of Topical Dermatological Medicines.局部用皮肤病药物的以患者为中心的设计
Pharmaceuticals (Basel). 2023 Apr 19;16(4):617. doi: 10.3390/ph16040617.
3
Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp.
采用创新的PAD技术配制的卡泊三醇倍他米松二丙酸酯乳膏基质用于治疗皮肤和头皮斑块状银屑病的感官特性分析。
Drugs Context. 2023 Mar 20;12. doi: 10.7573/dic.2023-2-8. eCollection 2023.
4
Polyaphron Dispersion Technology, A Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application.聚阿弗龙分散技术,一种结合药物渗透、局部耐受性和应用便利性的新型局部制剂及给药系统。
Dermatol Ther (Heidelb). 2022 Oct;12(10):2217-2231. doi: 10.1007/s13555-022-00794-y. Epub 2022 Sep 1.
5
In Vitro Evaluation of a Foamable Microemulsion Towards an Improved Topical Delivery of Diclofenac Sodium.体外评价一种泡沫型微乳对双氯芬酸钠经皮传递的改善作用。
AAPS PharmSciTech. 2022 Apr 4;23(4):102. doi: 10.1208/s12249-022-02258-0.
6
Strategies to Optimize Adherence in Patients with Mycosis Fungoides.蕈样肉芽肿患者的依从性优化策略。
Cells. 2021 Dec 30;11(1):113. doi: 10.3390/cells11010113.
7
Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits.丙酸氯倍他索与他扎罗汀固定组合治疗银屑病:作用机制与治疗益处的叙述性综述
Dermatol Ther (Heidelb). 2021 Aug;11(4):1157-1174. doi: 10.1007/s13555-021-00560-6. Epub 2021 Jun 9.
8
Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis.在实际应用中,卡泊三醇/倍他米松二丙酸酯泡沫辅助治疗可降低银屑病生物制剂成本且不降低疗效。
Dermatol Ther (Heidelb). 2020 Dec;10(6):1383-1396. doi: 10.1007/s13555-020-00454-z. Epub 2020 Oct 13.
9
Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study.卡泊三醇0.005%与二丙酸倍他米松0.064%固定复方泡沫治疗头皮斑块状银屑病的疗效:一项II期随机临床研究的附加分析
J Clin Aesthet Dermatol. 2020 May;13(5):12-18. Epub 2020 May 1.
10
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature.卡泊三醇/倍他米松二丙酸酯气雾剂泡沫治疗寻常型银屑病:病例系列及文献综述
Clin Cosmet Investig Dermatol. 2018 Oct 9;11:451-459. doi: 10.2147/CCID.S180698. eCollection 2018.